Published in Brain Sci on August 06, 2013
Renal stem cell reprogramming: Prospects in regenerative medicine. World J Stem Cells (2014) 0.87
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Core transcriptional regulatory circuitry in human embryonic stem cells. Cell (2005) 34.93
Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell (2008) 28.29
THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. Exp Cell Res (1965) 21.61
Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet (2000) 21.52
Direct conversion of fibroblasts to functional neurons by defined factors. Nature (2010) 18.76
Human induced pluripotent stem cells free of vector and transgene sequences. Science (2009) 17.16
Disease-specific induced pluripotent stem cells. Cell (2008) 16.95
Dissecting direct reprogramming through integrative genomic analysis. Nature (2008) 16.47
Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell (2008) 16.38
In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature (2008) 16.21
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell (2010) 15.58
Mediator and cohesin connect gene expression and chromatin architecture. Nature (2010) 14.34
Epigenetic memory in induced pluripotent stem cells. Nature (2010) 14.31
Gene regulation for higher cells: a theory. Science (1969) 14.19
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature (2011) 13.94
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell (2009) 13.02
Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med (2000) 11.35
Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol (2008) 10.97
Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell (2008) 10.34
Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol (2008) 10.29
c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell (2007) 8.46
Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res (2000) 7.87
Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature (2008) 7.60
Nanog is the gateway to the pluripotent ground state. Cell (2009) 7.27
Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell (2012) 7.17
Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature (2003) 6.92
Control of the embryonic stem cell state. Cell (2011) 6.89
Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature (2009) 6.85
MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science (1988) 6.78
Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol (2009) 6.76
Role of the polycomb protein EED in the propagation of repressive histone marks. Nature (2009) 6.62
A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature (1983) 6.52
Oct4-induced pluripotency in adult neural stem cells. Cell (2009) 6.50
Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell (1979) 6.47
Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Nat Cell Biol (2007) 6.30
Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature (2011) 5.84
Epigenetic dynamics of imprinted X inactivation during early mouse development. Science (2003) 5.80
Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci (2005) 5.66
MicroRNA-mediated conversion of human fibroblasts to neurons. Nature (2011) 5.59
Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med (2009) 5.50
Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell (2008) 5.40
Direct conversion of human fibroblasts to multilineage blood progenitors. Nature (2010) 5.35
Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science (1999) 5.13
Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell (2010) 5.13
Capturing pluripotency. Cell (2008) 5.08
Elite and stochastic models for induced pluripotent stem cell generation. Nature (2009) 5.06
Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci U S A (2011) 4.81
Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell (2011) 4.65
Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat Cell Biol (2011) 4.64
Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci (2003) 4.60
Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell (2002) 4.56
A chemical platform for improved induction of human iPSCs. Nat Methods (2009) 4.54
Direct reprogramming of human neural stem cells by OCT4. Nature (2009) 4.32
Transplantation of Living Nuclei From Blastula Cells into Enucleated Frogs' Eggs. Proc Natl Acad Sci U S A (1952) 4.32
DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nat Cell Biol (2004) 3.89
Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell (2010) 3.82
MicroRNA-mediated switching of chromatin-remodelling complexes in neural development. Nature (2009) 3.66
Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol (2003) 3.43
Direct conversion of C. elegans germ cells into specific neuron types. Science (2010) 3.31
PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. Mol Cell (2012) 3.28
Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse. Cell Stem Cell (2008) 3.04
Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med (2002) 3.04
Nuclear reprogramming in cells. Science (2008) 3.04
Stem cells: The promises and perils of p53. Nature (2009) 3.01
Direct lineage conversions: unnatural but useful? Nat Biotechnol (2011) 2.69
A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell (1988) 2.68
Generation of oligodendroglial cells by direct lineage conversion. Nat Biotechnol (2013) 2.64
Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells. Nat Biotechnol (2013) 2.53
Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell (2013) 2.51
"Fertile" intestine nuclei. Nature (1966) 2.16
Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature (1993) 2.00
Generation of human induced pluripotent stem cells from urine samples. Nat Protoc (2012) 1.76
Reprogramming of pericyte-derived cells of the adult human brain into induced neuronal cells. Cell Stem Cell (2012) 1.76
Molecular roadblocks for cellular reprogramming. Mol Cell (2012) 1.74
FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron (1990) 1.72
Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol (2003) 1.64
Phosphorylation of Sox2 cooperates in reprogramming to pluripotent stem cells. Stem Cells (2010) 1.48
Adult stem cell plasticity: fact or artifact? Annu Rev Cell Dev Biol (2003) 1.38
Sox2 and Oct-3/4: a versatile pair of master regulators that orchestrate the self-renewal and pluripotency of embryonic stem cells. Wiley Interdiscip Rev Syst Biol Med (2010) 1.25
ERG-associated protein with SET domain (ESET)-Oct4 interaction regulates pluripotency and represses the trophectoderm lineage. Epigenetics Chromatin (2009) 1.22
Single transcription factor reprogramming of hair follicle dermal papilla cells to induced pluripotent stem cells. Stem Cells (2011) 1.22
Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis. Exp Neurol (2004) 1.21
Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts. J Neurosci Res (1993) 1.16
NANOG maintains self-renewal of primate ES cells in the absence of a feeder layer. Genes Cells (2006) 1.13
Pioneer factors in embryonic stem cells and differentiation. Curr Opin Genet Dev (2010) 1.13
Neurogenic potential of human mesenchymal stem cells revisited: analysis by immunostaining, time-lapse video and microarray. J Cell Sci (2005) 1.11
Motor function analysis of myelin mutant mice using a rotarod. Int J Dev Neurosci (1995) 1.00
Transplantation of CNS fragments into the brain of shiverer mutant mice: extensive myelination by implanted oligodendrocytes. I. Immunohistochemical studies. Dev Neurosci (1985) 0.99
Sox2 acts through Sox21 to regulate transcription in pluripotent and differentiated cells. Curr Biol (2012) 0.98
Miracles and molecules--progress in spinal cord repair. Nat Neurosci (2002) 0.98
DNA sequence preferences of transcriptional activators correlate more strongly than repressors with nucleosomes. Mol Cell (2012) 0.97
Failed central nervous system regeneration: a downside of immune privilege? Neuromolecular Med (2005) 0.85
Teratogenic potential in cultures optimized for oligodendrocyte development from mouse embryonic stem cells. Stem Cells Dev (2010) 0.84
Cellular alchemy and the golden age of reprogramming. Cell (2012) 0.80
Stem cell-derived therapeutic myelin repair requires 7% cell replacement. Stem Cells (2008) 0.78
Grand challenge commentary: Chemical transdifferentiation and regenerative medicine. Nat Chem Biol (2010) 0.78
Adjunctive MSCs enhance myelin formation by xenogenic oligodendrocyte precursors transplanted in the retina. Cell Res (2010) 0.78